Chronic Obstructive Pulmonary Disease Drugs Market worth $ 14.27 bn by 2026

Chronic Obstructive Pulmonary Disease (COPD) was valued at US $10.78 billion in the year 2018 and is estimated to reach US $14.27 billion by 2026, at a CAGR of 3.57%. Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory lung disease that causes airflow obstruction and breathing difficulties. COPD is characterized by emphysema, chronic bronchitis, […]

Chronic Obstructive Pulmonary Disease Drugs Market worth $ 14.27 bn by 2026 Read More »